<SEC-DOCUMENT>0000886163-24-000056-index.html : 20240709
<SEC-HEADER>0000886163-24-000056.hdr.sgml : 20240709
<ACCEPTANCE-DATETIME>20240709165219
ACCESSION NUMBER:		0000886163-24-000056
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20240709
DATE AS OF CHANGE:		20240709
EFFECTIVENESS DATE:		20240709

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LIGAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0000886163
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				770160744
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-280733
		FILM NUMBER:		241107927

	BUSINESS ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-550-7500

	MAIL ADDRESS:	
		STREET 1:		3911 SORRENTO VALLEY BLVD
		STREET 2:		SUITE 110
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ligand-formsx8_july2024.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: ligand-formsx8_july2024.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exhibit107_july2024.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 2 - file: exhibit107_july2024.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ligand-51opiniontosx8final.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 3 - file: ligand-51opiniontosx8final.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>s-8_exhibit231x792024.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 4 - file: s-8_exhibit231x792024.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>contact.jpg
<TEXT>
Document 5 - file: contact.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>logo.jpg
<TEXT>
Document 6 - file: logo.jpg

</DOCUMENT>
</SEC-DOCUMENT>